https://orcid.org/0009-0004-9392-8816
References
- Min S, Hailin H, Mei Y, Xiaojuan L, Haiping W, Yanyi D. Accuracy comparison of detection results of different antimicrobial sensitivity test systems for Streptococcus pneumoniae. Lab Med Clin. 2019;16(03):410–412.
- Zhou M, Wang Y, Liu C, et al. Comparison of five commonly used automated susceptibility testing methods for accuracy in the China Antimicrobial Resistance Surveillance System (CARSS) hospitals. Infect Drug Resist. 2018;11:1347. doi:10.2147/IDR.S166790
- Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard. CLSI Document. M07-11st ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
- Biotech D. DL 96E Product Information. Zhuhai, Guangdong, China: DL Biotech Inc; 2003.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: CLSI Supplement M100. 30th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2020.
- Huang Y, Wang W, Zhao H, Wang Z. Verification process of American CLSI M52-commercial microbial identification system and antimicrobial susceptibility testing system. J Mod Lab Med. 2017;4:148–151.
- Standardization IOf. ISO 20776-2: Clinical Laboratory Testing and in vitro Diagnostic Test Systems. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices Part 2. Switzerland: International Organization for Standardization Geneva; 2021.
- Pfizer Pharmaceuticals Ltd. Instruction manual of cefoperazone sodium and sulbactam sodium for injection; 2016. Available from: https://labeling.pfizer.com/ShowLabeling.aspx?id=9837. Accessed June 01, 2023.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: CLSI Supplement M100. 32th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2022.
- Testing ECoAS. MIC and zone diameter distributions and ECOFFs: EUCAST; 2021. Available from: https://www.eucast.org/mic_distributions_and_ecoffs/. Accessed May 25, 2023.
- Minggui W, Guan X, He L, et al. Laboratory diagnosis, antibacterial treatment and hospital infection control of extensively drug-resistant gram-negative bacteria infection: a consensus of Chinese experts. Chin J Infect Chemother. 2017;17(01):82–92.
- Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;74(12):2089–2114.